Senate Bill 83 aims to amend the Medical Assistance program by prohibiting the Department of Health Services (DHS) from implementing any utilization management controls on antipsychotic prescription drugs that have been approved by the federal Food and Drug Administration (FDA). Utilization management controls are techniques used to assess the medical necessity and appropriateness of prescription drugs, which can include methods like prior authorization and step therapy protocols. The bill seeks to ensure that individuals receiving Medical Assistance, particularly those with limited financial resources, have unimpeded access to necessary antipsychotic medications.

The bill introduces a new section, 49.45 (9o), which defines "prescription drug" and "utilization management controls" within the context of the legislation. By explicitly stating that the DHS cannot impose these controls on FDA-approved antipsychotic drugs, the bill aims to enhance access to essential mental health treatments for vulnerable populations in Wisconsin.